Dr Roisin Stout and Dr Katie Best from the Lovat Group present their poster “Potential of endothelial AMBRA1 expression to identify high risk AJCC stage I/II non-ulcerated melanomas” at The Society for Melanoma Research 19th International Congress in Edinburgh. This work would not have been possible without the help of our NESRF.